You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EMPiRE

Showing 1 - 25 of 205
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pseudophakic Patients Previously Implanted With TECNIS Odyssey

Not yet recruiting
  • Cataracts
  • Intervention
  • Bakersfield, California
  • +2 more
Aug 17, 2023

Data on Johnson & Johnson Surgical Vision Products

Enrolling by invitation
  • Refractive Error
  • +2 more
  • Intervention
  • Bakersfield, California
    Empire Eye and Laser Center
Jan 23, 2023

ECG Methods for the Prompt Identification of Coronary Events

Active, not recruiting
  • Chest Pain
  • +3 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Jan 5, 2023

    Renal Impairment Trial in Rialto, Miami Lakes, Orlando (VIR-2218)

    Not yet recruiting
    • Renal Impairment
    • Rialto, California
    • +2 more
    Apr 24, 2023

    Atopic Dermatitis Trial in East Syracuse, Arlington (ruxolitinib cream)

    Recruiting
    • Atopic Dermatitis
    • ruxolitinib cream
    • East Syracuse, New York
    • +1 more
    Jan 13, 2023

    Hypertension Trial in United States (baxdrostat)

    Completed
    • Hypertension
    • Rialto, California
    • +4 more
    Jul 18, 2023

    Cataracts Trial in United States (Investigational Healon Endocoat, Control Healon EndoCoat)

    Not yet recruiting
    • Cataracts
    • Investigational Healon Endocoat
    • Control Healon EndoCoat
    • Bakersfield, California
    • +4 more
    Oct 7, 2022

    Hepatic Insufficiency, Healthy Trial in Rialto, Orlando, San Antonio (Imlunestrant)

    Recruiting
    • Hepatic Insufficiency
    • Healthy
    • Rialto, California
    • +2 more
    Jul 8, 2022

    Renal Impairment, Healthy Volunteers Trial in United States (ASP0367)

    Recruiting
    • Renal Impairment
    • Healthy Volunteers
    • Anniston, Alabama
    • +3 more
    Dec 22, 2022

    NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

    Recruiting
    • NON-ALCOHOLIC STEATOHEPATITIS
    • Rialto, California
    • +5 more
    Sep 19, 2023

    Renal Impairment, Hemodialysis Trial in United States (INCB000928)

    Recruiting
    • Renal Impairment
    • Hemodialysis
    • Rialto, California
    • +4 more
    Jul 20, 2022

    Cataracts Trial in United States (investigational IOL Model DEN00V, control IOL Model ZCB00/DCB00)

    Recruiting
    • Cataracts
    • investigational IOL Model DEN00V
    • control IOL Model ZCB00/DCB00
    • Bakersfield, California
    • +8 more
    Jan 23, 2023

    Meibomian Gland Dysfunction Trial in Bakersfield, Torrance, Hurst (Activator LFD-2100)

    Completed
    Has Results
    • Meibomian Gland Dysfunction
    • Activator LFD-2100
    • Bakersfield, California
    • +2 more
    Jan 13, 2022

    Ulcerative Colitis Trial in Worldwide (BT051 200 mg, BT051 800 mg, BT051 3200 mg)

    Completed
    • Ulcerative Colitis
    • BT051 200 mg
    • +3 more
    • Rialto, California
    • +5 more
    Dec 13, 2022

    Hepatocellular Carcinoma Trial in China, United States (CS1003+Lenvatinib, CS1003 Placebo+Lenvatinib)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Nofazinlimab (CS1003)+Lenvatinib
    • Nofazinlimab (CS1003) Placebo+Lenvatinib
    • Coronado, California
    • +5 more
    Nov 7, 2022

    Intensive Care Trial in London (Music session)

    Recruiting
    • Intensive Care
    • Music session
    • London, United Kingdom
      Chelsea and Westminster Hospital NHS Foundation Trust
    Aug 5, 2021

    Insulin Resistance - Type A, Insulin Resistance - Type B, Lipoatrophic Diabetes Trial in Japan (Empagliflozin Tablets)

    Active, not recruiting
    • Insulin Resistance - Type A
    • +3 more
    • Empagliflozin Tablets
    • Kobe, Hyogo, Japan
    • +4 more
    Jun 2, 2021

    Cataract, Corneal Astigmatism Trial in United States (TECNIS® Toric II)

    Completed
    Has Results
    • Cataract
    • Corneal Astigmatism
    • TECNIS® Toric II
    • Bakersfield, California
    • +6 more
    May 5, 2022

    Hepatic Impairment Trial in Rialto, Miami, San Antonio (belapectin)

    Completed
    • Hepatic Impairment
    • Rialto, California
    • +3 more
    Mar 24, 2022

    Non-alcoholic Fatty Liver Disease Trial in United States (AMG 609, Placebo)

    Recruiting
    • Non-alcoholic Fatty Liver Disease
    • AMG 609
    • Placebo
    • Chandler, Arizona
    • +9 more
    Dec 28, 2022

    Non-Alcoholic Fatty Liver Disease Trial in Japan, United States (LY3849891, Placebo)

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Rialto, California
    • +9 more
    Dec 8, 2022

    Advanced Malignancies Trial in United States (parsaclisib)

    Completed
    • Advanced Malignancies
    • Rialto, California
    • +4 more
    Mar 28, 2022

    Heart Failure, Obesity Trial in Herlev, Odense (Empagliflozin 10 MG, Placebo)

    Recruiting
    • Heart Failure
    • Obesity
    • Empagliflozin 10 MG
    • Placebo
    • Herlev, Denmark
    • +1 more
    Oct 6, 2021

    Obesity, Heart Failure Trial in Herlev, Odense (Empagliflozin 10 MG, Placebo)

    Recruiting
    • Obesity
    • Heart Failure
    • Empagliflozin 10 MG
    • Placebo
    • Herlev, Denmark
    • +1 more
    Sep 3, 2021

    Visual Acuity Trial in United States (Investigational senofilcon A C3 Multifocal Lens, delefilcon A Multifocal Lens)

    Completed
    Has Results
    • Visual Acuity
    • Investigational senofilcon A C3 Multifocal Lens
    • delefilcon A Multifocal Lens
    • Bakersfield, California
    • +6 more
    Dec 21, 2021